| Row | STUDYID | DOMAIN | ETCD | ELEMENT | TESTRL | TEENRL | TEDUR |
|---|
| 1 | EX1 | TE | SCRN | Screen | Informed consent | 1 week after start of Element | P7D |
| 2 | EX1 | TE | RI | Run-In | Eligibility confirmed | 2 weeks after start of Element | P14D |
| 3 | EX1 | TE | P | Usual | First dose of study product administration, where study product is usual tobacco productUsual Tobacco Product | 2 weeks after start of Element | P14D |
| 4 | EX1 | TE | A | Tobacco Product A | First dose of study product administration, where study product is Tobacco product Product A | 2 weeks after start of Element | P14D |
| 5 | EX1 | TE | B | Tobacco Product B | First dose of study product administration, where study product is Tobacco product Product B | 2 weeks after start of Element | P14D |
| 6 | EX1 | TE | FU | Follow-Up | First day of after end of study tobacco product administration | 1 week after start of Element | PD7 |